ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

INZY Inozyme Pharma Inc

4,63
-0,18 (-3,74%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Inozyme Pharma Inc INZY NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,18 -3,74% 4,63 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,74 4,61 4,835 4,63 4,81
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/05/202409:30GLOBEInozyme Pharma to Present at the Jefferies Global Healthcare..
23/05/202409:30GLOBEInozyme Pharma to Present Recently Announced Data from Phase..
08/05/202409:30GLOBEInozyme Pharma to Participate at the Bank of America..
07/05/202409:30GLOBEInozyme Pharma Reports First Quarter 2024 Financial Results..
03/05/202409:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
08/04/202407:30GLOBEInozyme Pharma Announces Positive Topline Data from Ongoing..
05/04/202419:00GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
02/04/202409:30GLOBEInozyme Pharma to Participate at the 23rd Annual Needham..
26/03/202409:30GLOBEInozyme Pharma to Report Topline Data from Ongoing Phase 1/2..
12/03/202409:30GLOBEInozyme Pharma Reports Full Year 2023 Financial Results and..
26/02/202410:30GLOBEInozyme Pharma to Participate in the TD Cowen 44th Annual..
06/02/202410:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
05/12/202310:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
09/11/202310:30GLOBEInozyme Pharma to Participate in Upcoming Investor..
07/11/202310:30GLOBEInozyme Pharma Reports Third Quarter 2023 Financial Results..
03/11/202317:15GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
26/10/202309:30GLOBEInozyme Pharma Announces Presentation at the American..
10/10/202309:30GLOBEInozyme Pharma Highlights Inclusion of Generalized Arterial..
06/10/202309:30GLOBEInozyme Pharma Announces Three Poster Presentations at the..
26/09/202308:30GLOBEInozyme Pharma Announces Positive Interim Data from Ongoing..
20/09/202309:30GLOBEInozyme Pharma to Host Virtual Investor and Analyst Event on..
06/09/202309:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
05/09/202309:30GLOBEInozyme Pharma to Present at the H.C. Wainwright 25th Annual..
08/08/202309:30GLOBEInozyme Pharma Reports Second Quarter 2023 Financial Results..
03/08/202317:01GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
01/08/202317:01GLOBEInozyme Pharma, Inc. Announces Closing of Public Offering of..
28/07/202300:20GLOBEInozyme Pharma, Inc. Announces Pricing of Public Offering of..
27/07/202317:33GLOBEInozyme Pharma, Inc. Announces Proposed Offering of Common..
26/07/202308:30GLOBEInozyme Pharma Announces Updates on Global Development..
19/07/202309:30GLOBEInozyme Pharma to Provide ENPP1 Deficiency Program Update on..
27/06/202309:30GLOBEInozyme Pharma Announces Dosing of First Infant with ENPP1..